Latest Breaking News On - Eton pharmaceuticals inc - Page 12 : comparemela.com

Harrow Health (NASDAQ:HROW) Releases Earnings Results, Misses Estimates By $0 01 EPS

Harrow Health (NASDAQ:HROW) Releases Earnings Results, Misses Estimates By $0 01 EPS
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesAmerica corpWalleye capitalNews ratings for harrow health dailySurface ophthalmics incHarrow health incPharmaceuticals incHarrow healthEton pharmaceuticals incEarnings history for harrow healthHarrow health price performanceGet free reportStreet groupMontreal canLake street capitalSurface ophthalmics

Eton Pharmaceuticals Inc (ETON) Tops Q2 EPS by 27c, beats revenue

Eton Pharmaceuticals Inc (ETON) Tops Q2 EPS by 27c, beats revenue
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Eton pharmaceuticals incEton pharmaceuticals

Eton Pharmaceuticals Reports Second Quarter 2023 Financial Results

Total Q2 revenue of $12.0 million and net income of $4.6 millionProduct sales and royalty revenue of $6.5 million up 175% from Q2 2022 and 22% from Q1 2023$21.6 million

Lisam wilsonSean brynjelsenCompany nasdaqEton pharmaceuticalsEton pharmaceuticals incExchange commissionCompany etonDevelopment rd expensesSite communications incAzurity pharmaceuticalsBetaine anhydrousRecent businessCarglumic acidEton caresAudio onlyPrivate securities litigation reform act

Eton Pharmaceuticals (ETON) to Release Quarterly Earnings on Thursday

Eton Pharmaceuticals (NASDAQ:ETON – Get Free Report) is set to release its earnings data after the market closes on Thursday, August 10th. Analysts expect Eton Pharmaceuticals to post earnings of ($0.09) per share for the quarter. Investors that are interested in participating in the company’s conference call can do so using this link. Eton Pharmaceuticals […]

Eton pharmaceuticalsEton pharmaceuticals stock downEton pharmaceuticals incRenaissance technologiesGoldman sachs group incJpmorgan chase coEton pharmaceuticals company profileEarnings history for eton pharmaceuticalsHedge funds weigh in on eton pharmaceuticalsNews ratings for eton pharmaceuticals dailyGet free reportPharmaceuticals stock downStreet groupSachs groupCarglumic acidN acetylglutamate synthase

Q2 2023 Earnings Estimate for Harrow Health, Inc Issued By B Riley (NASDAQ:HROW)

Harrow Health, Inc. (NASDAQ:HROW – Free Report) – Investment analysts at B. Riley lifted their Q2 2023 earnings estimates for shares of Harrow Health in a note issued to investors on Thursday, July 20th. B. Riley analyst M. Mamtani now forecasts that the company will earn $0.00 per share for the quarter, up from their […]

Eton pharmaceuticals incHarrow health price performancePharmaceuticals incHarrow health company profileSurface ophthalmics incNews ratings for harrow health dailyFred alger managementSquarepoint opsSteward partners investment advisoryHarrow health incHarrow healthFree reportGet free reportLake street capitalStreet corpPartners investment advisory